Nivolumab With or Without Ipilimumab in Treating Patients With Refractory Metastatic Anal Canal Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Eli Lilly and Company
Joint Authority for Päijät-Häme Social and Health Care
Eli Lilly and Company
National Cancer Institute (NCI)
Massachusetts General Hospital
Hoffmann-La Roche
National Cancer Institute (NCI)
Brown University
AstraZeneca
National Cancer Institute (NCI)
AstraZeneca
Seagen Inc.
City of Hope Medical Center
City of Hope Medical Center
Seagen Inc.
Beth Israel Deaconess Medical Center
M.D. Anderson Cancer Center
Astellas Pharma Inc
Hoffmann-La Roche
Idience Co., Ltd.
Jazz Pharmaceuticals
Sichuan Baili Pharmaceutical Co., Ltd.
UNC Lineberger Comprehensive Cancer Center
Bristol-Myers Squibb
MOMA Therapeutics
Cogent Biosciences, Inc.
University of Maryland, Baltimore
Chang Gung Memorial Hospital
Blokhin's Russian Cancer Research Center
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
Eli Lilly and Company
M.D. Anderson Cancer Center
Hoffmann-La Roche
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Icahn School of Medicine at Mount Sinai
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
AstraZeneca
OHSU Knight Cancer Institute
Hunter Holmes Mcguire Veteran Affairs Medical Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Cedars-Sinai Medical Center